Results

Total Results: 2,582 records

Showing results for "considering".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-selection-harms-systematic-reviews.pdf
    February 01, 2018 - Prioritization and Selection of Harms for Inclusion in Systematic Reviews Prioritization and Selection of Harms for Inclusion in Systematic Reviews Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Systematic Reviews Methods Guide www.ahrq.gov Presenter Presentation Notes P…
  2. effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
    January 01, 2010 - 45 Abstract Characterization of exposure is a central issue in the analysis of observational data; however, no “one size fits all” solution exists for exposure measurement. In this chapter, we discuss potential exposure measurement approaches for observational comparative effectiveness research (CER). First, it is …
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/celiac-disease_research-protocol.pdf
    June 12, 2014 - Existing reviews that we are considering including (in total or in part) as evidence will be assessed
  4. effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
    January 01, 2015 - - eg. page 35, line 28-29 'surprisingly' ; page 36 line 19-20 'this is especially important when considering
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
    December 08, 2014 - In considering the applicability of the findings to patients, we will consult large studies to ascertain
  6. effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
    May 26, 2016 - need to keep the scope of this project focused on disparities within the SMI population, rather than considering
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
    March 10, 2010 - It is too simplistic and not considering the research question, clinical and methodological diversity … substantial heterogeneity needs explanation, but lack of explanation should not diminish its impact when considering
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_consumer.pdf
    July 01, 2016 - Treatments for Fecal Incontinence: A Review of the Research for Adults Treatments for Fecal Incontinence A Review of the Research for Adults e Archived: This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current …
  9. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/are-there-data-supporting-the-discontinuance-of-warfarin-after-catheter-ablation-for-atrial-fibrillation-what-is-the-prevalence-of-symptomatic-and-asymptomatic-atrial-fibrillation-after-catheter-ablation
    February 27, 2012 - Home » Get Involved » Nominated Topics » Topic Suggestion Description Topic Suggestion Description Date submitted: February 27, 2012 Download Topic Suggestion Disposition [PDF · 54.6 KB] Briefly describe a specific question, or set of related questions, about a healt…
  10. effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
    August 01, 2013 - The horizon scanning team operationalizes this definition by considering interventions in the context … We also provide below reasons why these questions are asked and answered when considering whether a … While considering the presentations, team members and any guest attendees with subject matter expertise … ask experts for their opinions about patient acceptance or adoption of an intervention, we are also considering … These parameters are intended to serve as anchoring points for considering the overall potential impact
  11. effectivehealthcare.ahrq.gov/sites/default/files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
    November 12, 2020 - G-1. Additions to ROB Template Table G-2. Additions to risk of bias template Rater Author, Year Selection Bias Domain: Randomization Adequate? Selection Bias Domain: Allocation Concealment Adequate? Selection Bias Domain: Groups Similar at Baseline? Selection Bias Domain: ITT Analysis? Performance Bias Domain: Care P…
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
    November 12, 2020 - G-1. Additions to ROB Template Table G-2. Additions to risk of bias template Rater Author, Year Selection Bias Domain: Randomization Adequate? Selection Bias Domain: Allocation Concealment Adequate? Selection Bias Domain: Groups Similar at Baseline? Selection Bias Domain: ITT Analysis? Performance Bias Domain: Care P…
  13. effectivehealthcare.ahrq.gov/products/acute-pain-ems/protocol
    October 30, 2018 - Overall conclusions and SOE will be assessed considering how the effect estimates and the confidence
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-treatment-future_research.pdf
    February 01, 2012 - For each FRN topic, stakeholders were asked to provide a brief rationale (maximum 250 words) considering … When considering clinical outcomes, there is a potential for a large loss in followup. … Framework for Considering Study Designs for Future Research Needs (FRN). … Efficiency (i.e., considering the timing of the need for new evidence, it is likely that a result could … Costs associated with the likely study design are reasonable considering limited program resources
  15. effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
    April 01, 2016 - transportation, communications industries, health care) is underrepresented in included studies when considering
  16. effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_disposition-comments.pdf
    March 21, 2016 - In considering the interventions used most have been successful with certain SNF residents. … the ultimate goal of bringing the person back in line with what WE feel is best for him either not considering
  17. effectivehealthcare.ahrq.gov/products/hypothyroidism-hyperthyroidism-screening-treatment/research-protocol
    March 10, 2010 - This uncertainty impacts the decision-making for clinicians who are considering treatments for subclinical
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-approaches_research.pdf
    June 01, 2011 - This paper provides a framework for understanding the possibilities, considering influential factors … approach involves a consideration of the results of randomized trials (i.e., their conclusiveness) when considering … Our goal in this paper has been to provide a framework for understanding the possibilities, considering
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-2.pdf
    December 01, 2021 - Rapid Evidence Product: Masks for Prevention of COVID-19 in Community and Healthcare Settings Version 2 Rapid Evidence Product Version 2.0 (June 24, 2020) Masks for Prevention of COVID-19 in Community and Healthcare Settings Background and Purpose Currently, no proven treatments are available for coronavirus d…
  20. effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-Spanish-DA.pdf
    September 01, 2016 - ¿Es la prueba para detectar el cáncer pulmonar apropiada para mí? ¿Es la prueba para detectar el cáncer pulmonar apropiada para mí? Herramienta que le ayudará a decidir si está considerando hacerse la prueba para detectar el cáncer pulmonar con tomografía computarizada de dosis baja Si ha fumado durante mu…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: